Drug Price Increases Fall for Third Consecutive Year

After meeting with lawmakers in January, pharmaceutical leaders have again dropped price increases for the third year in a row. In 2017, only 5.5% of drugs rose by more than 10%, a 5% decrease from 2016 and a 10% decrease from 2015. These decreases have stalled drug...

Pfizer Releases Biosimilar Data, Rivals J&J

At the six-week mark of its fifty-four-week study, Pfizer released data for its biosimilar, Inflectra as a treatment for Crohn’s disease. Previously, Inflectra was approved to treat moderate to severe Crohn’s disease but did not have Crohn’s-specific data. With its...

FDA Approves Biotronik Coronary Stent

Biotronik has received FDA approval for its first bare-metal stent for coronary arteries. The device is intended for patients with new and recurring blockages in the coronary arteries between 2.25 and 4.0 mm in diameter and lesion lengths up to 31 mm. The PRO-Kinetic...

3D Printed Prosthetics Changing Medical Device Landscape

Due to cost, efficiency, and shorter time frames, many companies have begun printing prosthetics. The devices, used among children and adults alike, have found niche markets in underprivileged countries as the cost of traditional prosthetics rises. Many are claiming...

Artificial Intelligence Spotting Skin Cancer

Researchers from Stanford University have taken AI to the next level, turning computers into dermatologists, or, at least, basic skin cancer detectors. Through an image recognition algorithm, the computer program was able to detect a form of melanoma just as well as a...